中科生物(01237)发布中期业绩 股东应占溢利875.2万元 同比扭亏为盈

Group 1 - The core viewpoint of the article is that Zhongke Biological (01237) has reported a positive financial performance for the first half of 2025, with significant growth in revenue and a turnaround in profit [1] - The company's revenue reached 199.5 million yuan, representing a year-on-year increase of 6.98% [1] - Shareholders' profit attributable to the company was 8.752 million yuan, compared to a loss of 1.715 million yuan in the same period last year, indicating a successful turnaround [1] - The basic earnings per share were reported at 0.095 yuan [1]